Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists
- PMID: 3039110
Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists
Abstract
Cultured granule cells prepared from 8-day postnatal rats were used for the study of carbachol-induced phosphoinositide turnover. The addition of carbachol induced a 20- to 30-fold increase in [3H]inositol monophosphate (IP1) accumulation within 30 min in the presence of 20 mM LiCl in granule cells prelabeled with [3H]myoinositol. Carbachol also stimulated the formation of [3H]inositol bisphosphate and [3H]inositol trisphosphate assayed either in the presence or in the absence of lithium; the increase in [3H]inositol triphosphate and [3H]inositol biphosphate synthesis appeared to be faster in the time course but much smaller in amount when compared with the formation of [3H]IP1. The EC50 of carbachol was approximately 7 microM, and the saturation concentration was about 100 microM. This carbachol-induced response was completely blocked by two muscarinic acetylcholine receptor (mAChR) antagonists, atropine and pirenzepine, with a Ki of 0.5 and 120 nM, respectively. Saturation studies of the binding of [3H]N-methylscopolamine and [3H]quinuclidinyl benzilate to mAChRs in intact granule cells revealed the presence of a single class of binding sites with a Kd of 140 and 126 pM, respectively, and a Bmax of approximately 70 fmol/10(6) cells for both ligands. Within 1 hr after pre-exposure of cells to carbachol, the subsequent carbachol-induced [3H]IP1 accumulation was reduced by about 50%, whereas mAChR binding, assessed by using either [3H]N-methylscopolamine or [3H]quinuclidinyl benzilate, was unchanged. A second slower phase of desensitization was associated with a loss of mAChR binding sites; at 18 hr, the decrease of responsiveness was about 80%, whereas the loss of mAChR sites was about 60%.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.Mol Pharmacol. 1991 Dec;40(6):952-9. Mol Pharmacol. 1991. PMID: 1661840
-
Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.J Pharmacol Exp Ther. 1985 Mar;232(3):608-16. J Pharmacol Exp Ther. 1985. PMID: 2579230
-
Molecular mechanisms of homologous desensitization and internalization of muscarinic receptors in primary cultures of neonatal corticostriatal neurons.J Pharmacol Exp Ther. 1990 Apr;253(1):257-65. J Pharmacol Exp Ther. 1990. PMID: 2158546
-
Cardioselective muscarinic antagonists.Fed Proc. 1987 Jun;46(8):2523-35. Fed Proc. 1987. PMID: 3036606 Review. No abstract available.
-
Muscarinic receptor subtypes in the central nervous system.Int Rev Neurobiol. 1985;26:151-99. doi: 10.1016/s0074-7742(08)60074-4. Int Rev Neurobiol. 1985. PMID: 2410389 Review. No abstract available.
Cited by
-
Regulation of muscarinic receptor function in developing oligodendrocytes by agonist exposure.Br J Pharmacol. 2003 Jan;138(1):47-56. doi: 10.1038/sj.bjp.0705002. Br J Pharmacol. 2003. PMID: 12522072 Free PMC article.
-
Receptor-linked early events induced by vasoactive intestinal contractor (VIC) on neuroblastoma and vascular smooth-muscle cells.Biochem J. 1990 Nov 15;272(1):71-7. doi: 10.1042/bj2720071. Biochem J. 1990. PMID: 2124805 Free PMC article.
-
Interactions between Ca2+ mobilizing mechanisms in cultured rat cerebellar granule cells.J Physiol. 1992 Oct;456:667-80. doi: 10.1113/jphysiol.1992.sp019360. J Physiol. 1992. PMID: 1338107 Free PMC article.
-
Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cells.J Neurosci. 1994 Oct;14(10):5858-64. doi: 10.1523/JNEUROSCI.14-10-05858.1994. J Neurosci. 1994. PMID: 7931548 Free PMC article.
-
Desensitization of prostaglandin F2 alpha receptor-mediated phosphoinositide hydrolysis in cultured rat astrocytes.Neurochem Res. 1994 Jun;19(6):679-85. doi: 10.1007/BF00967706. Neurochem Res. 1994. PMID: 8065525